TRVITrevi Therapeutics, Inc.
$15.32+31% 1Y
$15.32
$9.9952 weeks$19.49
The business
How TRVI's business earns
- Share count, year on year
- +10%
Share count, year on year · more shares than a year ago
Details›
- Free cash flow, trailing twelve months
- −$62M
- Net income, trailing twelve months
- −$61M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry